Lobbying client

CENTRIENT PHARMACEUTICALS LLC

Pharmaceutical Manufacturing

Filings
28
Filed by
1
Reported in-house
—
Reported by firms
$1,920,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2020 to 2026

Filings

28 filings, newest first.
Filing Filed by Amount
3rd Quarter - Report (No Activity)
3rd Quarter 2026
AKIN GUMP STRAUSS HAUER & FELD — reported
2nd Quarter - Report (No Activity)
2nd Quarter 2026
AKIN GUMP STRAUSS HAUER & FELD — reported
1st Quarter - Report
1st Quarter 2026
AKIN GUMP STRAUSS HAUER & FELD $60,000 reported
4th Quarter - Report
4th Quarter 2025
AKIN GUMP STRAUSS HAUER & FELD $80,000 reported
3rd Quarter - Report
3rd Quarter 2025
AKIN GUMP STRAUSS HAUER & FELD $80,000 reported
2nd Quarter - Report
2nd Quarter 2025
AKIN GUMP STRAUSS HAUER & FELD $20,000 reported
1st Quarter - Report
1st Quarter 2025
AKIN GUMP STRAUSS HAUER & FELD $50,000 reported
4th Quarter - Report
4th Quarter 2024
AKIN GUMP STRAUSS HAUER & FELD $10,000 reported
3rd Quarter - Report
3rd Quarter 2024
AKIN GUMP STRAUSS HAUER & FELD $30,000 reported
2nd Quarter - Report
2nd Quarter 2024
AKIN GUMP STRAUSS HAUER & FELD $30,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
AKIN GUMP STRAUSS HAUER & FELD 25 $1,920,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 25
Pharmacy PHA 25
Manufacturing MAN 24
Defense DEF 7
Budget/Appropriations BUD 3
Trade (domestic/foreign) TRD 2

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 8070 118th 2
S. 4638 118th 2

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.